miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development

Lars Maegdefessel1, Joshua M Spin2, Uwe Raaz3

  • 11] Division of Cardiovascular Medicine, Stanford University, Falk CVRB, 300 Pasteur Drive, Stanford, California 94305, USA [2] Center for Molecular Medicine L8:03, Department of Medicine, Karolinska Institute and University Hospital, Stockholm 17176, Sweden.

Nature Communications
|November 1, 2014
PubMed
Summary

MicroRNAs (miRNAs) like miR-24 are key regulators of abdominal aortic aneurysm (AAA) progression. Targeting miR-24 and its effector Chi3l1 shows potential for treating AAA and offers new biomarkers for disease progression.

Related Concept Videos